key: cord-0720233-94w96xcv authors: Wadhera, Rishi K.; Shen, Changyu; Gondi, Suhas; Chen, Siyan; Kazi, Dhruv S.; Yeh, Robert W. title: Cardiovascular Deaths During the COVID-19 Pandemic in the United States date: 2021-01-19 journal: J Am Coll Cardiol DOI: 10.1016/j.jacc.2020.10.055 sha: 89bbe38627815950e908d83df507d29449eafa9a doc_id: 720233 cord_uid: 94w96xcv BACKGROUND: Although the direct toll of COVID-19 in the United States has been substantial, concerns have also arisen about the indirect effects of the pandemic. Hospitalizations for acute cardiovascular conditions have declined, raising concern that patients may be avoiding hospitals because of fear of contracting severe acute respiratory syndrome- coronavirus-2 (SARS-CoV-2). Other factors, including strain on health care systems, may also have had an indirect toll. OBJECTIVES: This investigation aimed to evaluate whether population-level deaths due to cardiovascular causes increased during the COVID-19 pandemic. METHODS: The authors conducted an observational cohort study using data from the National Center for Health Statistics to evaluate the rate of deaths due to cardiovascular causes after the onset of the pandemic in the United States, from March 18, 2020, to June 2, 2020, relative to the period immediately preceding the pandemic (January 1, 2020 to March 17, 2020). Changes in deaths were compared with the same periods in the previous year. RESULTS: There were 397,042 cardiovascular deaths from January 1, 2020, to June 2, 2020. Deaths caused by ischemic heart disease increased nationally after the onset of the pandemic in 2020, compared with changes over the same period in 2019 (ratio of the relative change in deaths per 100,000 in 2020 vs. 2019: 1.11, 95% confidence interval: 1.04 to 1.18). An increase was also observed for deaths caused by hypertensive disease (1.17, 95% confidence interval: 1.09 to 1.26), but not for heart failure, cerebrovascular disease, or other diseases of the circulatory system. New York City experienced a large relative increase in deaths caused by ischemic heart disease (2.39, 95% confidence interval: 1.39 to 4.09) and hypertensive diseases (2.64, 95% confidence interval: 1.52 to 4.56) during the pandemic. More modest increases in deaths caused by these conditions occurred in the remainder of New York State, New Jersey, Michigan, and Illinois but not in Massachusetts or Louisiana. CONCLUSIONS: There was an increase in deaths caused by ischemic heart disease and hypertensive diseases in some regions of the United States during the initial phase of the COVID-19 pandemic. These findings suggest that the pandemic may have had an indirect toll on patients with cardiovascular disease. A lthough the direct toll of the novel coronavirus disease 2019 in the United States has been substantial (1), concerns have also arisen about the indirect effects of the pandemic on higher-risk patients with chronic medical conditions such as cardiovascular disease. Recent reports suggest large increases in mortality during the pandemic that cannot be explained by COVID-19 deaths alone (2) (3) (4) . At the same time, hospitalizations for acute cardiovascular conditions, including myocardial infarction, heart failure, and stroke, have declined precipitously (5) (6) (7) . These patterns have raised concern that patients may be avoiding hospitals because of fear of contracting severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) and that some may have died of cardiovascular conditions without seeking medical care (8, 9) . Other factors, including the deferral of outpatient cardiovascular visits, diagnostic testing, and semielective procedures, as well as greater strain on health care systems, may also have unintended effects on higher-risk patients. Evaluating if population-level deaths due to cardiovascular causes have increased over this period could provide important insights on whether the pandemic has had an indirect toll and may also inform public health responses and policy efforts in states that are currently experiencing a surge in COVID-19 cases. Therefore, in this study, we aimed to answer 2 questions: First, did population-level deaths due to cardiovascular causes (ischemic heart disease, (I00-I09, I26-I49, I51, I52, I70-I99 Figure 1 and Supplemental Table 2 . There was a nationwide increase in deaths caused by ischemic heart disease after the onset of the Weekly death rates (per 100,000 population) by underlying cause (ischemic heart disease, heart failure, hypertensive diseases, cerebrovascular disease, and other circulatory diseases) are shown in red for January to June 2020, and in blue for the same period in 2019. Conditions considered "other diseases of the circulatory system" include pulmonary embolism, pericarditis, myocarditis, and cardiac arrest. The vertical dashed line represents the onset of the US pandemic (third week of March 2020), when states began experiencing rapid increases in reported COVID-19 cases and implementing stay-at-home orders. Overall, there was an increase in deaths caused by ischemic heart disease and hypertensive disease after the onset of the pandemic. The COVID-19 Pandemic and Cardiovascular Deaths The COVID-19 Pandemic and Cardiovascular Deaths J A N U A R Y 1 9 , 2 0 2 1 : 1 5 9 -6 9 Weekly death rates (per 100,000 population) by underlying cause (ischemic heart disease, heart failure, hypertensive diseases, cerebrovascular disease, and other circulatory diseases) are shown in red for January to June 2020, and in blue for the same period in 2019. Conditions considered "other diseases of the circulatory system" include pulmonary embolism, pericarditis, myocarditis, and cardiac arrest. The The Other diseases of COVID-19: United States Cases by County Estimation of excess deaths associated with the COVID-19 pandemic in the United States Excess deaths from COVID-19 and other causes Fewer hospitalizations for acute cardiovascular conditions during the COVID-19 pandemic Admissions to veterans affairs hospitals for emergency conditions during the COVID-19 pandemic The Covid-19 pandemic and the incidence of acute myocardial infarction Characteristics associated with out-of-hospital cardiac arrests and resuscitations during the novel coronavirus disease National Center for Health Statistics. Weekly counts of death by jurisdiction and cause of death Centers for Disease Control and Prevention, 2020. 11. National Center for Health Statistics. Excess Deaths Associated with COVID-19 Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic After deaths at home spike in NYC, officials plan to count many as COVID-19 There's been a spike in people dying at home in several cities; that suggests coronavirus deaths are higher than reported Out-of-hospital cardiac arrest during the Covid-19 outbreak in Italy Out-of-hospital cardiac arrest response and outcomes during the COVID-19 pandemic The impact of the COVID-19 pandemic on outpatient visits: changing patterns of care in the newest COVID-19 hot spots Facing Covid-19 in Italy: ethics, logistics, and therapeutics on the epidemic's front line Case rates, treatment approaches, and outcomes in acute myocardial infarction during the coronavirus disease 2019 pandemic Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19) Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19) Clinical characteristics of Covid-19 in New York City Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality Place and causes of acute cardiovascular mortality during the COVID-19 pandemic Variation in COVID-19 hospitalizations and deaths across New York City boroughs Hospitalization and mortality among black patients and white patients with Covid-19 Community-level factors associated with racial and ethnic disparities in COVID-19 rates In Massachusetts KEY WORDS cardiovascular disease, coronavirus disease 2019, COVID-19 pandemic, mortality APPENDIX For supplemental tables, please see the online version of this paper.